GlassScriptPhysician profile
Houman Khalili
NPI 1104084631
$30,299.73
in general payments reported to CMS, 2019-2025
17 companies · $13K in 2025
The $13K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,106 · 2020: $1,711 · 2021: $2,590 · 2022: $1,431 · 2023: $505 · 2024: $2,409 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $2,346 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,237.50 |
| Food and Beverage | $2,346.13 |
| Travel and Lodging | $877.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,740.44 | 2019-2025 | Triclip |
| Shockwave Medical, INC | $9,637.45 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $6,655.83 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abiomed | $699.32 | 2019-2025 | Impella |
| Boston Scientific Corporation | $636.96 | 2019-2024 | Rotapro |
| Angiodynamics, INC. | $260.03 | 2023-2024 | Angiovac |
| Atricure, INC. | $148.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $147.22 | 2019-2022 | |
| Medtronic Vascular, INC. | $122.55 | 2019-2020 | |
| Biosense Webster, INC. | $43.66 | 2021 | |
| Medtronic, INC. | $43.21 | 2021 | |
| Cardiva Medical, INC. | $40.83 | 2020-2024 | Savvywire |
| Terumo Medical Corporation | $35.62 | 2022-2023 | Angio-Seal, Azur Cx Detachable |
| Teleflex LLC | $29.76 | 2022 | |
| Cardiovascular Systems INC. | $26.10 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Houman Khalili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.